Agios Pharmaceuticals のニュースと活動

Agios PharmaceuticalsはSagard Holdingsの所有です。 Sagard Holdings は 4 の国に直接拠点を置いています。

Sagard HoldingsはAcheel,Achieve,ADITを含む11の子会社があります。

彼らはにいます：

• 保険25%
• 金融サービス17%
• その他58%

21人の主要幹部と一緒に組織図を見る

Agios Pharmaceuticalsでもっとも検索された略歴

• Brian Goff, Chief Executive Officer and Director
• Maykin Ho, Director
• Catherine Owen, Director

更新履歴 - ％sの

• Chief Technology OfficerのKris Hansenは退社しました (2026年1月5日公開されたニュース).

アラートを作成
Agios Pharmaceuticals のエグゼクティブの異動をフォローします。

Sagard HoldingsはSanofi (フランス共和国),Eli Lilly (アメリカ合衆国（米国）),Moderna (アメリカ合衆国（米国）)を含む1,913の競合企業を有します。

Popular M&A news in 医薬品

• Corden Pharma has announced the acquisition of AmbioPharm  (2026年6月5日に公開).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (2026年6月4日に公開).
• ％sは、％s百万ドルの資金調達を発表しました。 (2026年6月3日に公開).

医薬品業界でのその他のコンタクトの提案

• Johnson & Johnson 社 Joaquin Duato - Chief Executive Officer and Chairman of the Board
• Abbott 社 Robert Ford - Chief Executive Officer and Chairman of the Board
• Larimar Therapeutics 社 Jonathan Leff - Director

医薬品業界についてさらに知る

％sによる最新のプレスリリース

• Agios to Webcast Conference Call of Third Quarter 2020 Financial Results on November 5, 2020 | Agios Pharmaceuticals, Inc.
• Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or Refractory IDH1-mutant Acute Myeloid Leukemia | Agios Pharmaceuticals, Inc.
• Agios Announces Final Overall Survival Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients | Agios Pharmaceuticals, Inc.
• Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs | Agios Pharmaceuticals, Inc.
• Agios to Present at the Citi 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020 | Agios Pharmaceuticals, Inc.
• Agios to Present at the Virtual Canaccord 40th Annual Growth Conference on Thursday, August 13, 2020 | Agios Pharmaceuticals, Inc.
• Agios Reports Business Highlights and Second Quarter 2020 Financial Results | Agios Pharmaceuticals, Inc.
• Agios to Webcast Conference Call of Second Quarter 2020 Financial Results on July 30, 2020 | Agios Pharmaceuticals, Inc.
• Agios to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference on Tuesday, June 23, 2020 | Agios Pharmaceuticals, Inc.
• Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia | Agios Pharmaceuticals, Inc.
• View more press releases Close

％sについてのソーシャルメディア

• Agios Pharmaceuticals についてのウィキペディア,Google News & Yahoo Financeの記事
• Agios Pharmaceuticals についてのLinkedIn,ツイッター & YouTubeの記事